Key facts
- It has raised $780K; the latest was Later Stage VC ($780K) in Jan 2025.
- Notable investors include Eleven Ventures, ABHI US Accelerator.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Sqilline
- ·The full record, as it builds
Funding rounds
No funding rounds for Sqilline are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sqilline
Developer of an AI-driven real-world data (RWD) platform designed to accelerate medical research and improve patient outcomes. The company's platform integrates data structuring, processing, and analysis from electronic health records as well as offers clinical research services and scientific research services, enabling physicians to have advanced decision support for clinical trials and rare disease management, thereby improving healthcare efficiency and innovation.
- Sector
- Healthcare
- HQ
- Sofia, Bulgaria
- Founded
- 2009
- Employees
- 36
- Website
- sqilline.com/
- Ownership
- Privately Held (backing)
Sqilline doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sqilline shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sqilline in its N-PORT filings yet. We sweep new filings monthly.